Brief: Targovax Receives Fast-Track Designation For ONCOS-102

Circio Holding ASA

15/02/2021 06:06

Feb 15 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX RECEIVES FAST-TRACK DESIGNATION FOR ONCOS-102
    * US FDA GRANTS ONCOS-102 FAST-TRACK DESIGNATION FOR
MALIGNANT
PLEURAL MESOTHELIOMA
    * FAST-TRACK APPROVAL COMES IN ADDITION TO ONCOS-102'S
EXISTING
ORPHAN DRUG DESIGNATION (ODD) WITH BOTH US FDA AND EUROPEAN EMA
IN MESOTHELIOMA INDICATION

Source text for Eikon:  ID:nWkr429jGj 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))